LOGIN  |  REGISTER
Surmodics

Pennant Group Acquires Senior Living Operations in Wisconsin

March 20, 2023 | Last Trade: US$20.30 0.41 2.06

EAGLE, Idaho, March 20, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has completed the acquisition of operations of Robins Landing at New Berlin, a 44-bed memory care and assisted living facility located in New Berlin, Wisconsin, and Robins Landing at Brookfield, a 52-bed memory care and assisted living facility located in Brookfield, Wisconsin. The acquisition was effective March 16, 2023 and will be subject to a long-term, triple-net lease.

“We are very excited to expand our senior living offerings in the State of Wisconsin,” said Brent Guerisoli, Chief Executive Officer of Pennant. “This acquisition complements our existing operations in the area, including home health, hospice, and a strong network of senior living communities,” Guerisoli added.

“We could not be happier to add Robins Landing at New Berlin, and Robins Landing at Brookfield. Our Wisconsin leaders are eager and excited by the opportunity to turn these operations into the employers of choice and communities of choice in New Berlin and Brookfield,” added Andrew Rider, President of Pinnacle Senior Living LLC, Pennant’s senior living subsidiary.

Mr. Guerisoli reaffirmed that Pennant continues to pursue opportunities to acquire high quality home health, hospice, home care and senior living businesses throughout the United States.

About Pennant:

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 95 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Contact Information

The Pennant Group, Inc.
(208) 506-6100
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB